Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma

There are significant health disparities between Māori and non‐Māori with asthma, a pattern seen between other ethnic populations. This study investigates outcomes for Māori in a randomized controlled trial (RCT) of combination budesonide/formoterol inhaler therapy in asthma.

[1]  A. Rodgers,et al.  Recruiting equal numbers of indigenous and non-indigenous participants to a ‘polypill’ randomized trial , 2013, International Journal for Equity in Health.

[2]  D. Shaw,et al.  Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. , 2013, The Lancet. Respiratory medicine.

[3]  Cynthia Damba,et al.  Perceived barriers in accessing food among recent Latin American immigrants in Toronto , 2013, International Journal for Equity in Health.

[4]  D. Shaw,et al.  Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. , 2013, The journal of allergy and clinical immunology. In practice.

[5]  C. Vogelmeier,et al.  Budesonide/Formoterol Maintenance and Reliever Therapy in Asian Patients (Aged ≥16 Years) with Asthma , 2012, Clinical Drug Investigation.

[6]  R. Beasley,et al.  Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use. , 2012, Journal of Allergy and Clinical Immunology.

[7]  D. Voaklander,et al.  Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies. , 2012, Canadian respiratory journal.

[8]  Randall Brown,et al.  Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: a randomized controlled trial. , 2012, The Journal of allergy and clinical immunology.

[9]  E. R. Sutherland,et al.  Impact of race on asthma treatment failures in the asthma clinical research network. , 2011, American journal of respiratory and critical care medicine.

[10]  B. Gorman,et al.  Racial and ethnic differences in adult asthma prevalence, problems, and medical care , 2009, Ethnicity & health.

[11]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[12]  C. Jenkins,et al.  Asthma in Indigenous Australians: so much yet to do for Indigenous lung health , 2009, The Medical journal of Australia.

[13]  R. L. OSullivan.  Book Review: Hauora Maori Standards of Health IV: A study of the years 20002005, edited by B Robson and R Harris , 2009 .

[14]  P. Kuna,et al.  Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations , 2007, International journal of clinical practice.

[15]  Papaarangi Reid,et al.  Hauora: Māori Standards of Health IV , 2007 .

[16]  K. Rabe,et al.  Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study , 2006, The Lancet.

[17]  P. Thompson,et al.  Formoterol Turbuhaler as reliever medication in patients with acute asthma , 2006, European Respiratory Journal.

[18]  P-C. Yang,et al.  Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. , 2006, Pulmonary pharmacology & therapeutics.

[19]  Brian Hurwitz,et al.  Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis , 2005, The Lancet.

[20]  H. Bisgaard,et al.  Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. , 2005, American journal of respiratory and critical care medicine.

[21]  R. Beasley,et al.  The use of the self-management plan system of care in adult asthma. , 2004, Primary care respiratory journal : journal of the General Practice Airways Group.

[22]  N. Pearce,et al.  Regional variations in asthma hospitalisations among Maori and non-Maori. , 2004, The New Zealand medical journal.

[23]  D. Mannino,et al.  Determinants of Quality of Life Among People with Asthma: Findings from the Behavioral Risk Factor Surveillance System , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[24]  N. Pearce,et al.  Time trends and seasonal patterns of asthma deaths and hospitalisations among Maori and non-Maori. , 2002, The New Zealand medical journal.

[25]  N. Pearce,et al.  Asthma morbidity 6 yrs after an effective asthma self-management programme in a Maori community. , 2000, The European respiratory journal.

[26]  N. Pearce,et al.  He Mate Huango: an update on Maori asthma. , 2000, Pacific health dialog.

[27]  N. Pearce,et al.  Long‐term benefits for Mäori of an asthma self‐management program in a Mäori community which takes a partnership approach , 1999, Australian and New Zealand journal of public health.

[28]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[29]  N. Pearce,et al.  β agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality? , 1999 .

[30]  N. Pearce,et al.  Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? , 1999, The Journal of allergy and clinical immunology.

[31]  R. Dockhorn,et al.  Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. , 1998, The Journal of allergy and clinical immunology.

[32]  S. Hales,et al.  Geographical variation in the prevalence of asthma symptoms in New Zealand. , 1997, The New Zealand medical journal.

[33]  L. Crossland,et al.  The self reported prevalence of asthma symptoms amongst adult New Zealanders. , 1994, The New Zealand medical journal.

[34]  L. Crossland,et al.  Community-based asthma care: trial of a "credit card" asthma self-management plan. , 1994, The European respiratory journal.

[35]  J. Crane,et al.  Trial of an asthma action plan in the Maori community of the Wairarapa. , 1993, The New Zealand medical journal.

[36]  N. Pearce,et al.  Asthma in Maori people. , 1992, The New Zealand medical journal.

[37]  J. Garrett,et al.  Reasons for racial differences in A & E attendance rates for asthma. , 1989, The New Zealand medical journal.

[38]  F. Speizer,et al.  The circumstances preceding death from asthma in young people in 1968 to 1969. , 1971, British journal of diseases of the chest.